Literature DB >> 11689647

Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails.

B M Ward1, B Moss.   

Abstract

Two mechanisms have been proposed for the intracellular movement of enveloped vaccinia virus virions: rapid actin polymerization and microtubule association. The first mechanism is used by the intracellular pathogens Listeria and Shigella, and the second is used by cellular vesicles transiting from the Golgi network to the plasma membrane. To distinguish between these models, two recombinant vaccinia viruses that express the B5R membrane protein fused to enhanced green fluorescent protein (GFP) were constructed. One had Tyr(112) and Tyr(132) of the A36R membrane protein, which are required for phosphorylation and the nucleation of actin tails, conservatively changed to Phe residues; the other had the A36R open reading frame deleted. Although the Tyr mutant was impaired in Tyr phosphorylation and actin tail formation, digital video and time-lapse confocal microscopy demonstrated that virion movement from the juxtanuclear region to the periphery was saltatory with maximal speeds of >2 microm/s and was inhibited by the microtubule-depolymerizing drug nocodazole. Moreover, this actin tail-independent movement was indistinguishable from that of a control virus with an unmutated A36R gene and closely resembled the movement of vesicles on microtubules. However, in the absence of actin tails, the Tyr mutant did not induce the formation of motile, virus-tipped microvilli and had a reduced ability to spread from cell to cell. The deletion mutant was more severely impaired, suggesting that the A36R protein has additional roles. Optical sections of unpermeabilized, B5R antibody-stained cells that expressed GFP-actin and were infected with wild-type vaccinia virus revealed that all actin tails were associated with virions on the cell surface. We concluded that the intracellular movement of intracellular enveloped virions occurs on microtubules and that the motile actin tails enhance extracellular virus spread to neighboring cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689647      PMCID: PMC114752          DOI: 10.1128/JVI.75.23.11651-11663.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.

Authors:  R Blasco; B Moss
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

2.  Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane.

Authors:  R W Doms; R Blumenthal; B Moss
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

3.  Interaction of assembled progeny pox viruses with the cellular cytoskeleton.

Authors:  G Hiller; K Weber; L Schneider; C Parajsz; C Jungwirth
Journal:  Virology       Date:  1979-10-15       Impact factor: 3.616

4.  Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination.

Authors:  E J Wolffe; S N Isaacs; B Moss
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

5.  Vaccinia virus induces cell fusion at acid pH and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein.

Authors:  S C Gong; C F Lai; M Esteban
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

6.  Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus.

Authors:  J E Parkinson; G L Smith
Journal:  Virology       Date:  1994-10       Impact factor: 3.616

7.  Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network.

Authors:  M Schmelz; B Sodeik; M Ericsson; E J Wolffe; H Shida; G Hiller; G Griffiths
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

8.  Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes.

Authors:  J Tooze; M Hollinshead; B Reis; K Radsak; H Kern
Journal:  Eur J Cell Biol       Date:  1993-02       Impact factor: 4.492

9.  Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment.

Authors:  G Hiller; K Weber
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

10.  The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.

Authors:  M Engelstad; G L Smith
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

View more
  86 in total

1.  Identification of second-site mutations that enhance release and spread of vaccinia virus.

Authors:  Ehud Katz; Elizabeth Wolffe; Bernard Moss
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Investigation of structural and functional motifs within the vaccinia virus A14 phosphoprotein, an essential component of the virion membrane.

Authors:  Jason Mercer; Paula Traktman
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

3.  Mutations in the vaccinia virus A33R and B5R envelope proteins that enhance release of extracellular virions and eliminate formation of actin-containing microvilli without preventing tyrosine phosphorylation of the A36R protein.

Authors:  Ehud Katz; Brian M Ward; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

4.  Increased interaction between vaccinia virus proteins A33 and B5 is detrimental to infectious extracellular enveloped virion production.

Authors:  Winnie M Chan; Brian M Ward
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

5.  The A33-dependent incorporation of B5 into extracellular enveloped vaccinia virions is mediated through an interaction between their lumenal domains.

Authors:  Winnie M Chan; Brian M Ward
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

6.  There is an A33-dependent mechanism for the incorporation of B5-GFP into vaccinia virus extracellular enveloped virions.

Authors:  Winnie M Chan; Brian M Ward
Journal:  Virology       Date:  2010-04-07       Impact factor: 3.616

7.  The pseudorabies virus VP1/2 tegument protein is required for intracellular capsid transport.

Authors:  G W Gant Luxton; Joy I-Hsuan Lee; Sarah Haverlock-Moyns; Joseph Martin Schober; Gregory Allan Smith
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 8.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

9.  Development and comparison of a quantitative TaqMan-MGB real-time PCR assay to three other methods of quantifying vaccinia virions.

Authors:  Jonathon L Baker; Brian M Ward
Journal:  J Virol Methods       Date:  2013-11-08       Impact factor: 2.014

10.  Transport of African swine fever virus from assembly sites to the plasma membrane is dependent on microtubules and conventional kinesin.

Authors:  Nolwenn Jouvenet; Paul Monaghan; Michael Way; Thomas Wileman
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.